Show simple item record

dc.contributor.authorPaulides, M.M.
dc.contributor.authorDobsicek, Trefna, H.
dc.contributor.authorRodrigues, D.B.
dc.date.accessioned2020-04-14T14:28:51Z
dc.date.available2020-04-14T14:28:51Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85082830387&doi=10.1016%2fj.addr.2020.03.004&partnerID=40&md5=12705ba77d6cd2cf3a966245fb8e4d7a
dc.identifier.urihttp://hdl.handle.net/10713/12553
dc.description.abstractHyperthermia therapy is a potent enhancer of chemotherapy and radiotherapy. In particular, microwave (MW) and radiofrequency (RF) hyperthermia devices provide a variety of heating approaches that can treat most cancers regardless the size. This review introduces the physics of MW/RF hyperthermia, the current state-of-the-art systems for both localized and regional heating, and recent advancements in hyperthermia treatment guidance using real-time computational simulations and magnetic resonance thermometry. Clinical trials involving RF/MW hyperthermia as adjuvant for chemotherapy are also presented per anatomical site. These studies favor the use of adjuvant hyperthermia since it significantly improves curative and palliative clinical outcomes. The main challenge of hyperthermia is the distribution of state-of-the-art heating systems. Nevertheless, we anticipate that recent technology advances will expand the use of hyperthermia to chemotherapy centers for enhanced drug delivery. These new technologies hold great promise not only for (image-guided) perfusion modulation and sensitization for cytotoxic drugs, but also for local delivery of various compounds using thermosensitive liposomes.en_US
dc.description.sponsorshipParts of this work was financially supported by the Dutch Cancer Society (KWF) , the Dutch Research Council (NWO) and the Top Sector Life Science & Health (LSH) , all in the Netherlands: grants 11368 , 15195 and 17918 . This project also has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 845645 .en_US
dc.description.urihttps://doi.org/10.1016/j.addr.2020.03.004en_US
dc.language.isoen_USen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofAdvanced Drug Delivery Reviews
dc.subjectDrug deliveryen_US
dc.subjectHyperthermiaen_US
dc.subjectMicrowaveen_US
dc.subjectRadiofrequencyen_US
dc.titleRecent technological advancements in radiofrequency- andmicrowave-mediated hyperthermia for enhancing drug deliveryen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.addr.2020.03.004
dc.identifier.pmid32229271


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record